Artikelaktionen

Sie sind hier: Startseite › … › Forschungsförderung › EU und Internationale … › Information About Programs

Information About Programs

 

Below, you will find information on EU and international research programs:

Horizon Europe

Horizon Europe is the current European Union’s framework programme for research and innovation with a budget of €95.5 billion up to 2027. Horizon Europe offers a broad range of funding opportunities, from support for basic scientific research to application-oriented collaborative projects and market launch activities.

Structure of Horizon Europe

Horizon Europe is structured in three central pillars:

  • Excellent Science
  • Global Challenges and European Industrial Competitiveness
  • Innovative Europe

 

An additional underlying pillar “Widening Participation and Strengthening the European Research Area” supports the entire programme and serves to optimise national research and innovation potential across Europe, thereby strengthening the European Research Area.

Source: factsheet “Horizon Europe - Investing to shape our future“ of the European Commission

The first pillar "Excellent Science" primarily supports bottom up (individual) research at all levels and includes the European Research Council, Marie Skłodowska-Curie Actions and Research Infrastructures.

The second pillar “Global Challenges & European Industrial Competiveness” comprises six thematic clusters, including the Cluster Health. This part of the programme provides funding for collaborative research, in which partners from different countries work together on a project. Applications can only be submitted in relation to topics within six different areas of intervention: 1) Health throughout the Life Course, 2) Environmental and Social Health Determinants, 3) Non-Communicable and Rare Diseases, 4) Infectious Diseases, including poverty-related and neglected diseases, 5) Tools, Technologies and Digital Solutions for Health and Care, including personalised medicine, 6) Health Care Systems.

The third pillar “Innovative Europe” bundles together instruments with a focus on innovation and market uptake. These include, among others, the European Innovation Council. From basic research to the marketability of a product, this creates a wide range of participation opportunities.

Horizon Europe introduces missions for the first time in Pillar II to increase the effectiveness of funding by pursuing clearly defined targets. Five missions have been identified, one of which is the Mission Cancer. This mission addresses the understanding of cancer, prevention, diagnosis and treatment, quality of life and equal access to care. In addition, partnerships within the Cluster Health contribute to the implementation of Horizon Europe.

More information about Horizon Europe can be found here.

Current calls for proposals on Horizon Europe can be found here.

EU4Health

The EU4Health program contributes to the European Union's objective of tackling long-term health challenges by building stronger, more resilient and more accessible health systems.

EU4Health is one of the main instruments to pave the way to a European Health Union.

Established by Regulation (EU) 2021/522EN, EU4Health brings an EU added value and complements the policies of the Member States to pursue four general objectives ten specific objectives representing the areas of intervention:

  • Improve and foster health
    • Health promotion and disease prevention, in particular cancer
    • International health initiatives and cooperation
  • Protect people
    • Prevention, preparedness and response to cross-border health threats
    • Complementing national stockpiling of essential crisis-relevant products
    • Establishing a reserve of medical, healthcare and support staff
  • Access to medicinal products, medical devices and crisis-relevant products
    • Ensuring that these products are accessible, available and affordable
  • Strengthen health systems
    • Reinforcing health data, digital tools and services, digital transformation of healthcare
    • Enhancing access to healthcare
    • Developing and implementing EU health legislation and evidence-based decision making
    • Integrated work among national health systems

European Partnerships, Joint Programming and Joint Transnational Calls

European Partnerships are means for cooperation between the European Commission, EU- Member States, the private sector and other stakeholders, to turn research results into socio-economic outcomes, and in turn, strengthen and adapt the European industry to major challenges such as digitisation and climate change.

These partnerships are instruments for aligning research, technology development and innovation with European political priorities and for creating synergies with national and regional programmes.

European Partnerships come into place when the objectives of Horizon Europe can be better achieved by this instrument than through other activities in the framework programme.

European Partnerships serve to complement European, national and regional initiatives.

A common strategic planning process has led to the approval of 49 partnership proposals.

Horizon Europe is the most important framework for implementing these partnerships. The (financial) engagement of EU-Member States and the European industry is important.

There are now three distinctly different types of European Partnerships:

Co-funded Partnerships (these bring together national and regional funding organisations and issue calls for proposals for transnational projects), Institutionalised Partnerships (for long-term commitment and a greater degree of integration; based on Article 185 or 187 of the Treaty on the Functioning of the European Union) and Co-Programmed Partnerships.

 

European Partnerships in the field of health

In addition to calls for proposals within Cluster 1 “Health”, a number of European Partnerships provide additional funding opportunities in the field of health, which are supported by Horizon Europe funds.

The following partnerships are either already in operation or are currently in preparation:

Interreg

The Interreg Upper Rhine Program 2021-2027 funds cross-border collaborative projects in the metropolitan region Upper Rhine, namely the areas of Alsace, southern Palatine, Baden and the cantons of Northwestern Switzerland. The program is funded by the European Fund for Regional Development (EFRD). Interreg Upper Rhine focuses addressing on a number of challenges that are common to all parts of the Upper Rhine region, such as mobility, climate change, cross-border public health issues as well as on reinforcing the research, development and innovation capacities in the region.

The Interreg Upper Rhine Program is based on the principle of co-financing. Researchers interested in submitting proposals to open calls should note that own funding has to be provided. The program's share in the overall project costs will vary depending on the respective priority and the specific goals addressed by the call, but the recipient's funds usually cover 50% of the planned project costs.

Link: https://www.interreg-oberrhein.eu/

National Institutes of Health (NIH) and Other US-Grants

European scientists are eligible to apply for grants of the National Institutes of Health (NIH) and other US-grants. NIH’s most popular grant programme is the so-called Research Project Grant (R01), which supports a discrete, specified and circumscribed research project. R01 grants are generally awarded for 3-5 years. The maximum amount of funding is not specified for the R01, unless it is stated in the specific Funding Opportunity Announcement (FAO). Applications for the R01 grant can be submitted three times a year (February, June, October). Direct costs are reimbursed up to 100%, whereas for the reimbursement of indirect costs, a current overhead of 8% has been set for foreign institutions.

Please note: The Medical Center – University of Freiburg can only participate in NIH funding or other US-funded grants as a sub-awardee or sub-recipient (and not as main-awardee). Applying for external funding from US funding institutions often involves a great deal of administrative work and is subject to strict regulations. Therefore, please as early as possible, if you are planning on applying.

 

Are you planning to apply for a US-Grant as sub-​awardee?

Please immediately and we will be happy to support you. Depending on the funder, an extensive and mandatory procedure may be involved.

  • We check formal aspects of your application.
  • We solicit signatures.
  • You obtain budget approval from your responsible employee of the third-party funding administration department.

Have you successfully acquired the grant? Congratulations!

Some administrative issues lie ahead before the contracts can be signed. Please immediately and we will be happy to support you.

  • We check formal aspects of your award and/or agreement
  • We will arrange – upon request - for a legal check of the regulations regarding intellectual property
  • We solicit signatures
  • You will contact the main awardee for their policy of “Financial Conflict of Interest” (FCOI).
      Please note that you must adhere to the guidelines of the main awardee.

International Foundations  

There are a large number of European and international foundations. They have different legal forms and allocate public and/or private funds.

Under certain circumstances, the signature of a person authorised to sign on behalf of the institution may already be required at the time of application - at the latest, however, when the project is approved (e.g. for institutional assurance letter, institutional acceptance letter).

Please inform the or the staff member in charge at Third-Party Funding Administration in good time about your intention to submit an application to a European or international foundation.